AIM
NVAX icon

Advantage Investment Management’s Novavax NVAX Stock Holding History

Advantage Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-25
Closed -$4K – 893
2015
Q4 		$4K Hold
25
– – ﹤0.01% 719
2015
Q3 		$4K Hold
25
– – ﹤0.01% 686
2015
Q2 		$6K Sell
25
-25
-50% -$4.39K ﹤0.01% 674
2015
Q1 		$8K Sell
50
-25
-33% -$4.06K ﹤0.01% 631
2014
Q4 		$9K Buy
+75
New +$7.84K 0.01% 540

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Advantage Investment Management's NVAX Position: Q1 2016 in Review

Advantage Investment Management sold out of Novavax (NVAX) in Q1 2016, closing a stake of 25 shares — an estimated $4K sold.

Advantage Investment Management first reported a position in NVAX in Q4 2014 and held it in 5 quarters. The position peaked at $9K in Q4 2014. 175 funds tracked by Wall St. Rank hold NVAX as of Q1 2016.

  • Advantage Investment Management reported no remaining Novavax position as of Q1 2016 after selling out during the quarter.
  • Advantage Investment Management sold 25 Novavax shares in Q1 2016, an estimated $4K.
  • Advantage Investment Management first reported a position in Novavax in Q4 2014 and held it in 5 quarters.
  • Advantage Investment Management's Novavax position peaked at $9K in Q4 2014.
  • 175 funds tracked by Wall St. Rank held Novavax as of Q1 2016.

Based on Advantage Investment Management's 13F filing for Q1 2016, filed 27 Mar 2017.